Rectal Cancer
A Phase 1 Study of RGX-202-01, a Small Molecule Inhibitor of the Creatine Transporter, SLC6a8, as a Single Agent and as Combination Therapy in Patients with Advanced Gastrointestinal Malignancies with Select Expansion Cohorts (RGX-202-001)
- Details
ClinicalTrials.gov ID:
NCT03597581
Diagnosis Type:
NA
USOR Number:
- Address
,
P: